RELAPSED CANCER
Clinical trials for RELAPSED CANCER explained in plain language.
Never miss a new study
Get alerted when new RELAPSED CANCER trials appear
Sign up with your email to follow new studies for RELAPSED CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation schedule aims to ease path to CAR t for lymphoma patients
Disease control CompletedThis study tested a new radiation therapy schedule for people with B-cell lymphoma that has come back or not responded to treatment. Participants received radiation once a week for five weeks before their CAR T-cell therapy. The goal was to see if this schedule makes radiation ea…
Matched conditions: RELAPSED CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New combo therapy shows promise for young cancer patients who relapsed
Disease control CompletedThis early-phase study tested a combination of three treatments—pembrolizumab, decitabine, and targeted radiation—in 22 children and young adults (ages 1 to 40) with relapsed or refractory solid tumors or lymphoma. The main goals were to see if the combination is safe and tolerab…
Matched conditions: RELAPSED CANCER
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated May 12, 2026 13:40 UTC